Feasibility of Romiplostim Discontinuation in Adult Thrombopoietin-Receptor Agonist Responsive Patients with Primary Immune Thrombocytopenia: An Observational Retrospective Report in Real Life Clinical Practice

Thrombopoietin mimetics are new treatment options for patients with immune throm-bocytopenia (ITP). Because of their mechanism of action, long-term administration was envisioned in order to maintain effective thrombopoiesis. We report on 30 romiplostim treated patients: 13/27 responders (48%) achiev...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hematol Rep
Glavni autori: Carpenedo, Monica, Cantoni, Silvia, Coccini, Veronica, Fedele, Marilena, Morra, Enrica, Pogliani, Enrico Maria
Format: Artigo
Jezik:Inglês
Izdano: PAGEPress Publications, Pavia, Italy 2015
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378205/
https://ncbi.nlm.nih.gov/pubmed/25852848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5673
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items